Artelo Biosciences stock surges after receiving favorable UK regulatory guidance

Investing.com — Artelo Biosciences (NASDAQ: ARTL) stock surged 18% after the company received favorable guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for a Phase 1 …